May 20, 2009 Health Informatics Seminar, 4:00-5:00 pm
Up one levelOn-line genomic resources for researchers
Presenter
Simon Gregory, PhD
View the recording of this event.
Biosketch
Simon G. Gregory, PhD, is an Assistant Professor in the Section of
Medical Genetics, Department of Medicine. Dr. Gregory's role in the
Duke CHG is to apply the experience gained from leading the mapping of
the mouse genome and sequencing human chromosome 1 to elucidating the
molecular mechanisms underlying multi-factorial diseases. His primary
area of research involves the identification of the complex genetic
factors that give rise to the development of cardiovascular
disease and the detection of genes involved in multiple
sclerosis. Dr. Gregory's group is also pioneering the application
of high-resolution
genomic micro arrays for the discovery of chromosomal abnormalities
and identification of epigenetic factors associated with human diseases
such as cancer and autism. This project aims to correlate copy number
profiles and factors such as methylation, with clinical phenotypes and
differential levels of gene expression. His areas of special expertise
are genome mapping, positional cloning and determining the effect that
sequence variation has upon the etiology of genetic disease. Dr.
Gregory is also director of the CHG
Molecular Genetics Core facility and the Duke Bioinformatics
Workshop, a forum for researchers to gain in-depth experience of
using publicly available molecular genomics databases.
Abstract
The finished sequence of the human genome represents an invaluable
resource that will greatly accelerate scientific research. However, the
bewildering array of genomic information, analysis tools, and ancillary
databases are difficult to navigate without being properly equipped
with skills necessary to make optimal use of these data. The major
factors that will influence the use of this vast amount of data is the
awareness of the diversity of data that is publicly available and the
skills required to make full use of it. This lecture will touch on the
content, i.e. utilization of evolving biological databases and the
innovative tools with which they are queried, and the inherent
strengths and weaknesses of the analyses they perform.